Effect  ||| S:0 E:7 ||| NN
of  ||| S:7 E:10 ||| IN
botulinum  ||| S:10 E:20 ||| JJ
toxin  ||| S:20 E:26 ||| NN
type  ||| S:26 E:31 ||| NN
A  ||| S:31 E:33 ||| DT
injection  ||| S:33 E:43 ||| NN
on  ||| S:43 E:46 ||| IN
lower  ||| S:46 E:52 ||| JJR
facial  ||| S:52 E:59 ||| JJ
contouring  ||| S:59 E:70 ||| NN
evaluated  ||| S:70 E:80 ||| VBD
using  ||| S:80 E:86 ||| VBG
a  ||| S:86 E:88 ||| DT
three-dimensional  ||| S:88 E:106 ||| JJ
laser  ||| S:106 E:112 ||| NN
scan  ||| S:112 E:117 ||| NN
To  ||| S:117 E:120 ||| TO
use  ||| S:120 E:124 ||| VB
three-dimensional  ||| S:124 E:142 ||| JJ
( ||| S:142 E:143 ||| -LRB-
3D ||| S:143 E:145 ||| NNP
)  ||| S:145 E:147 ||| -RRB-
laser  ||| S:147 E:153 ||| NN
scanning  ||| S:153 E:162 ||| VBG
to  ||| S:162 E:165 ||| TO
elucidate  ||| S:165 E:175 ||| VB
changes  ||| S:175 E:183 ||| NNS
in  ||| S:183 E:186 ||| IN
the  ||| S:186 E:190 ||| DT
external  ||| S:190 E:199 ||| JJ
facial  ||| S:199 E:206 ||| JJ
contour  ||| S:206 E:214 ||| NN
before  ||| S:214 E:221 ||| IN
and  ||| S:221 E:225 ||| CC
after  ||| S:225 E:231 ||| IN
botulinum  ||| S:231 E:241 ||| JJ
toxin  ||| S:241 E:247 ||| NN
type  ||| S:247 E:252 ||| NN
A  ||| S:252 E:254 ||| DT
( ||| S:254 E:255 ||| -LRB-
BoNT-A ||| S:255 E:261 ||| NNP
)  ||| S:261 E:263 ||| -RRB-
injections ||| S:263 E:273 ||| NNS
.  ||| S:273 E:275 ||| .
BoNT-A  ||| S:275 E:282 ||| NNP
was  ||| S:282 E:286 ||| VBD
injected  ||| S:286 E:295 ||| VBN
into  ||| S:295 E:300 ||| IN
15  ||| S:300 E:303 ||| CD
volunteers  ||| S:303 E:314 ||| NNS
as  ||| S:314 E:317 ||| IN
a  ||| S:317 E:319 ||| DT
treatment  ||| S:319 E:329 ||| NN
for  ||| S:329 E:333 ||| IN
lower  ||| S:333 E:339 ||| JJR
facial  ||| S:339 E:346 ||| JJ
contouring ||| S:346 E:356 ||| NN
.  ||| S:356 E:358 ||| .
A  ||| S:358 E:360 ||| DT
total  ||| S:360 E:366 ||| NN
of  ||| S:366 E:369 ||| IN
25  ||| S:369 E:372 ||| CD
U  ||| S:372 E:374 ||| NNP
of  ||| S:374 E:377 ||| IN
BoNT-A  ||| S:377 E:384 ||| NNP
was  ||| S:384 E:388 ||| VBD
injected  ||| S:388 E:397 ||| VBN
into  ||| S:397 E:402 ||| IN
each  ||| S:402 E:407 ||| DT
side  ||| S:407 E:412 ||| NN
of  ||| S:412 E:415 ||| IN
the  ||| S:415 E:419 ||| DT
masseter  ||| S:419 E:428 ||| JJ
muscle  ||| S:428 E:435 ||| NN
bilaterally ||| S:435 E:446 ||| NN
.  ||| S:446 E:448 ||| .
On  ||| S:448 E:451 ||| IN
each  ||| S:451 E:456 ||| DT
side ||| S:456 E:460 ||| NN
,  ||| S:460 E:462 ||| ,
it  ||| S:462 E:465 ||| PRP
was  ||| S:465 E:469 ||| VBD
injected  ||| S:469 E:478 ||| VBN
into  ||| S:478 E:483 ||| IN
two  ||| S:483 E:487 ||| CD
points  ||| S:487 E:494 ||| NNS
at  ||| S:494 E:497 ||| IN
the  ||| S:497 E:501 ||| DT
center  ||| S:501 E:508 ||| NN
of  ||| S:508 E:511 ||| IN
the  ||| S:511 E:515 ||| DT
lower  ||| S:515 E:521 ||| JJR
third  ||| S:521 E:527 ||| JJ
of  ||| S:527 E:530 ||| IN
the  ||| S:530 E:534 ||| DT
masseter  ||| S:534 E:543 ||| JJ
muscle  ||| S:543 E:550 ||| NN
separated  ||| S:550 E:560 ||| NN
by  ||| S:560 E:563 ||| IN
1  ||| S:563 E:565 ||| CD
cm ||| S:565 E:567 ||| NNS
.  ||| S:567 E:569 ||| .
The  ||| S:569 E:573 ||| DT
clinical  ||| S:573 E:582 ||| JJ
effects  ||| S:582 E:590 ||| NNS
of  ||| S:590 E:593 ||| IN
BoNT-A  ||| S:593 E:600 ||| NNP
were  ||| S:600 E:605 ||| VBD
evaluated  ||| S:605 E:615 ||| VBN
by  ||| S:615 E:618 ||| IN
performing  ||| S:618 E:629 ||| VBG
3D  ||| S:629 E:632 ||| CD
laser  ||| S:632 E:638 ||| NN
scans  ||| S:638 E:644 ||| VBZ
before  ||| S:644 E:651 ||| RB
and  ||| S:651 E:655 ||| CC
4 ||| S:655 E:656 ||| CD
,  ||| S:656 E:658 ||| ,
8 ||| S:658 E:659 ||| CD
,  ||| S:659 E:661 ||| ,
12 ||| S:661 E:663 ||| CD
,  ||| S:663 E:665 ||| ,
and  ||| S:665 E:669 ||| CC
24  ||| S:669 E:672 ||| CD
weeks  ||| S:672 E:678 ||| NNS
after  ||| S:678 E:684 ||| IN
the  ||| S:684 E:688 ||| DT
injection ||| S:688 E:697 ||| NN
.  ||| S:697 E:699 ||| .
The  ||| S:699 E:703 ||| DT
mean  ||| S:703 E:708 ||| JJ
values  ||| S:708 E:715 ||| NNS
of  ||| S:715 E:718 ||| IN
the  ||| S:718 E:722 ||| DT
volume  ||| S:722 E:729 ||| NN
and  ||| S:729 E:733 ||| CC
widths  ||| S:733 E:740 ||| NN
of  ||| S:740 E:743 ||| IN
the  ||| S:743 E:747 ||| DT
most  ||| S:747 E:752 ||| RBS
prominent  ||| S:752 E:762 ||| JJ
area  ||| S:762 E:767 ||| NN
at  ||| S:767 E:770 ||| IN
each  ||| S:770 E:775 ||| DT
time  ||| S:775 E:780 ||| NN
point  ||| S:780 E:786 ||| NN
differed  ||| S:786 E:795 ||| VBZ
significantly  ||| S:795 E:809 ||| RB
before  ||| S:809 E:816 ||| RB
and  ||| S:816 E:820 ||| CC
4 ||| S:820 E:821 ||| CD
,  ||| S:821 E:823 ||| ,
8 ||| S:823 E:824 ||| CD
,  ||| S:824 E:826 ||| ,
12 ||| S:826 E:828 ||| CD
,  ||| S:828 E:830 ||| ,
and  ||| S:830 E:834 ||| CC
24  ||| S:834 E:837 ||| CD
weeks  ||| S:837 E:843 ||| NNS
after  ||| S:843 E:849 ||| IN
the  ||| S:849 E:853 ||| DT
injection ||| S:853 E:862 ||| NN
.  ||| S:862 E:864 ||| .
The  ||| S:864 E:868 ||| DT
volumes  ||| S:868 E:876 ||| NNS
and  ||| S:876 E:880 ||| CC
widths  ||| S:880 E:887 ||| NN
of  ||| S:887 E:890 ||| IN
the  ||| S:890 E:894 ||| DT
most  ||| S:894 E:899 ||| RBS
prominent  ||| S:899 E:909 ||| JJ
areas  ||| S:909 E:915 ||| NNS
of  ||| S:915 E:918 ||| IN
the  ||| S:918 E:922 ||| DT
lower  ||| S:922 E:928 ||| JJR
face  ||| S:928 E:933 ||| NN
( ||| S:933 E:934 ||| -LRB-
masseter  ||| S:934 E:943 ||| JJ
muscle ||| S:943 E:949 ||| NN
)  ||| S:949 E:951 ||| -RRB-
were  ||| S:951 E:956 ||| VBD
significantly  ||| S:956 E:970 ||| RB
lower  ||| S:970 E:976 ||| JJR
4 ||| S:976 E:977 ||| CD
,  ||| S:977 E:979 ||| ,
8 ||| S:979 E:980 ||| CD
,  ||| S:980 E:982 ||| ,
12 ||| S:982 E:984 ||| CD
,  ||| S:984 E:986 ||| ,
and  ||| S:986 E:990 ||| CC
24  ||| S:990 E:993 ||| CD
weeks  ||| S:993 E:999 ||| NNS
after  ||| S:999 E:1005 ||| IN
injecting  ||| S:1005 E:1015 ||| VBG
BoNT-A  ||| S:1015 E:1022 ||| JJ
than  ||| S:1022 E:1027 ||| IN
before  ||| S:1027 E:1034 ||| IN
the  ||| S:1034 E:1038 ||| DT
injection ||| S:1038 E:1047 ||| NN
.  ||| S:1047 E:1049 ||| .
The  ||| S:1049 E:1053 ||| DT
mean  ||| S:1053 E:1058 ||| JJ
values  ||| S:1058 E:1065 ||| NNS
of  ||| S:1065 E:1068 ||| IN
the  ||| S:1068 E:1072 ||| DT
volume  ||| S:1072 E:1079 ||| NN
and  ||| S:1079 E:1083 ||| CC
widths  ||| S:1083 E:1090 ||| NN
of  ||| S:1090 E:1093 ||| IN
the  ||| S:1093 E:1097 ||| DT
most  ||| S:1097 E:1102 ||| RBS
prominent  ||| S:1102 E:1112 ||| JJ
area  ||| S:1112 E:1117 ||| NN
were  ||| S:1117 E:1122 ||| VBD
2,176.93  ||| S:1122 E:1131 ||| CD
mm ||| S:1131 E:1133 ||| NNS
( ||| S:1133 E:1134 ||| -LRB-
3 ||| S:1134 E:1135 ||| LS
)  ||| S:1135 E:1137 ||| -RRB-
and  ||| S:1137 E:1141 ||| CC
2.39  ||| S:1141 E:1146 ||| CD
mm  ||| S:1146 E:1149 ||| NN
less ||| S:1149 E:1153 ||| RBR
,  ||| S:1153 E:1155 ||| ,
respectively ||| S:1155 E:1167 ||| RB
,  ||| S:1167 E:1169 ||| ,
24  ||| S:1169 E:1172 ||| CD
weeks  ||| S:1172 E:1178 ||| NNS
after  ||| S:1178 E:1184 ||| IN
the  ||| S:1184 E:1188 ||| DT
injection  ||| S:1188 E:1198 ||| NN
than  ||| S:1198 E:1203 ||| IN
before ||| S:1203 E:1209 ||| RB
.  ||| S:1209 E:1211 ||| .
